Author

Louisa Boateng

University of Pennsylvania

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Genetic & Genomic Medicine· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:ATAC-seq· 1 Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Alessandra ChesiiD· 1 shared Aura María RamíreziD· 1 shared Emily Greenfest‐AlleniD· 1 shared Fulai JiniD· 1 shared Gao T. WangiD· 1 shared Gerard D. SchellenbergiD· 1 shared Jeffery M. VanceiD· 1 shared Jeffrey CifelloiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenetic & Genomic Medicine

Alessandra ChesiORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Integrated genomic analysis and CRISPRi implicates EGFR in Alzheimer's disease risk

Yuk Yee Leung, Pavel P. Kuksa, Luke Carter, Jeffrey Cifello, Emily Greenfest‐Allen, Otto Valladares, Louisa Boateng, Shannon Laub, Natalia M. Tulina, Sofia Moura, Aura María Ramírez, Katrina Celis, Fulai Jin, Ru Feng, Gao T. Wang, , Li‐San Wang

The paper identifies EGFR as a potential therapeutic target in Alzheimer's disease by linking a risk variant to increased EGFR expression in brain cell types through genomic analysis and CRISPRi validation.

npj Dementia · Dec 16, 2025Peer-reviewedGenetic & Genomic Medicine